In the Product
The running trial, in the product.
Vivo is the control tower for your active trial: what's happening, what changed since you last looked, what needs your attention, and the recommended action — always in view, always traceable to source.
Trial Home — Daily View
Trial Home gives study teams a continuously updated view of what is happening across the trial, what changed since the last review, what needs attention, and what actions are pending. Designed for the rhythm of real clinical development work.
Every oversight view drills through to the underlying records — subject, visit, site, and source — so review never ends at a chart.
Actual vs. planned screening and enrollment, with trial- and site-level forecasts — slippage visible while there is still time to act on it.
The full subject picture — history, events, visits, and measures on one longitudinal timeline.
AE and SAE review in clinical context, with evidence packages assembled for DSMB and safety committees.
Labs, questionnaires, assessments, and ECG intervals over time — plus imaging reads with read operations, turnaround, and e-signature status where imaging vendors are connected.
Enrollment, deviations, data quality, and visit compliance ranked across sites — best practices surfaced, laggards flagged.
Scheduled analyses run on your cadence. Findings arrive as alerts, and alerts become tracked actions with owners and history.
Every one of these views is a workspace: filter it, plot it, save it, export it — the same pattern on every dataset in the trial, from adverse events to imaging reads.
Vivo tracks each site's lifecycle via ISF and TMF integration: activation progress, document readiness, conduct signals, and closeout status — connected to the same operating picture as enrollment, safety, and data quality.
Site Lifecycle
"Our CMO went from spending a week plus manually collating and creating the various tables he wanted for DSMB to maybe 30, 45 minutes. That's just transformative to how we do business."
VP, Clinical Operations · Alzheimer's Disease Global Phase 2 TrialLive with sponsors today. Most teams are running active trial oversight in 6–8 weeks.